Melissa Foster, Author at Cancer Therapy Advisor

Pacritinib induced significant and sustained spleen volume reduction and symptom control in patients

General Oncology

Bone-metastatic Cancer: Zoledronic Acid and Skeletal Events

By

Melissa Foster

January 6, 2017

Less frequent dosing with zoledronic acid does not increase fracture risk in patients with bone metastases.

$Lenvatinib improved progression-free survival and response rate in I-131–refractory thyroid cancer.$

Endocrine Cancer

Improved Progression-Free Survival, Response Rate with Lenvatinib in I-131

By

Melissa Foster

February 12, 2015

Lenvatinib improved progression-free survival and response rate in I-131-refractory thyroid cancer.

Flavopiridol + FOLFOX 'Active' Against Some Late-relapse Germ Cell Tumors

Head and Neck Cancer

Gabapentin Has Benefits in Oropharyngeal Cancer

By

Kathy Boltz, PhD

Melissa Foster

May 5, 2014

ANAHEIM, CALIFORNIA—Among oropharyngeal patients receiving radiotherapy, gabapentin improved pain management and reduced weight loss, which potentially prevents the need for placement of a gastrostomy tube.

Brain Cancer

Intra-arterial Chemo Beneficial for Recurrent Glioblastoma

By

Kathy Boltz, PhD

Melissa Foster

May 5, 2014

ANAHEIM, CALIFORNIA—For patients with recurrent glioblastoma, carboplatin-based intra-arterial chemotherapy is relatively safe and well-tolerated, with quality of life being maintained or improved during treatment.

Colored x-ray of a large cancerous bladder tumor (white) / Science Source

Urologic Cancers

Active Voiding Protocol Better After Urologic/Gynecologic Surgery

By

Kathy Boltz, PhD

Melissa Foster

May 3, 2014

ANAHEIM, CALIFORNIA—An active voiding protocol after urologic/gynecologic surgery led to improvements in patient satisfaction, reduced costs, and allowed for a less time-intensive procedure for nurses.

Endocrine Cancer

How to Minimize Radiation Exposure in Thyroid Cancer Care

By

Kathy Boltz, PhD

Melissa Foster

May 3, 2014

ANAHEIM, CALIFORNIA—Three principles can help nurses minimize radiation exposure levels when caring for patients receiving high-dose ablative therapy for thyroid cancer, according to research presented at the Oncology Nursing Society (ONS) 39th Annual Congress.

Palbociclib Extends Progression-free Survival in ER-positive/HER2-negative Breast Cancer

Pain Management

Nurses Collaborate to Facilitate Shared Decisions on Palliative Sedation

By

Kathy Boltz, PhD

Melissa Foster

May 3, 2014

ANAHEIM, CALIFORNIA—A multidisciplinary approach that also heavily incorporates input from patients and their families helped alleviate concerns about inappropriate use of palliative sedation and improved patient-centered care, a speaker said at the Oncology Nursing Society (ONS) 39th Annual Congress.